首页/数据集/Comparison of retinopathy incidence among the 80mW, 100mW and 120mW groups after RVO.

Comparison of retinopathy incidence among the 80mW, 100mW and 120mW groups after RVO.

NIAID Data Ecosystem2026-05-02 收录

数据链接：

https://figshare.com/articles/dataset/Comparison_of_retinopathy_incidence_among_the_80mW_100mW_and_120mW_groups_after_RVO_/26050803 数据链接链接失效反馈

官方服务：

资源简介：

Comparison of retinopathy incidence among the 80mW, 100mW and 120mW groups after RVO.

应用场景：

创建时间：

2024-06-17

相关数据集

Comparison of eyes with CRVO and BRVO.

视网膜静脉阻塞

眼科研究

Data are presented as the mean±standard deviation, number(%), or median(range). logMAR = Logarithm of the minimum angle of resolution. 1Kruskal-Wallis H test. 2Fisher’s exact test. 3Mann-Whitney U tes

NIAID Data Ecosystem70

Additional file 1: Table S1. of Optic disc morphology in unilateral branch retinal vein occlusion using spectral domain optical coherence tomography

视网膜静脉阻塞

视盘形态分析

Demographical data (age; gender; hypertension, diabetes mellitus) type of occlusion, affected eye, SER, BCVA, AL, ONH parameters and SSI of affected and unaffected fellow eyes of our BRVO study subjec

Figshare2016-12-16 更新40

Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.

视网膜静脉阻塞

临床疗效评估

Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.

Figshare2018-09-20 更新20

Supplementary Material for: Central Retinal Vein Occlusion after mRNA COVID-19 Vaccination

视网膜静脉阻塞

疫苗不良反应

A 47-year-old man presented with visual loss in the right eye 8 h after the first dose of a coronavirus disease 2019 (COVID-19) vaccine developed by Pfizer/BioNTech (BNT162b2). The best corrected visu

Figshare2023-05-25 更新40

TO STUDY RISK FACTORS AND CLINICAL PROFILE OF BRVO AT A TERTIARY CARE CENTRE

视网膜静脉阻塞

眼健康风险因素

Introduction: After diabetic retinopathy, retinal vein occlusion is the second most prevalent retinal vascular condition. BRVO is brought on by blockage of the retinas branch vein, which affects a spe

NIAID Data Ecosystem30